Graves' disease and Hashimoto's thyroiditis in monozygotic twins: Case study as well as transcriptomic and immunohistological analysis of thyroid tissues

European Journal of Endocrinology

Volumn 154, Issue 1, 2006, Pages 13-20

  Aust, G ^b   Krohn, K ^a   Morgenthaler, N G ^c   Schroder S ^b   Schutz A ^b   Edelmann, J ^b   Brylla, E ^b  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c BRAHMS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; COMPLEMENTARY DNA; LIOTHYRONINE; PROTEINASE; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE; CD22 ANTIGEN; CD8 ANTIGEN; COLLAGEN TYPE 4; CYTOKINE; IODINE; KI 67 ANTIGEN; LAMININ; THYROID PEROXIDASE; THYROTROPIN RECEPTOR ANTIBODY; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; CELL MIGRATION; DNA MICROARRAY; ENVIRONMENTAL FACTOR; EXTRACELLULAR MATRIX; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENETIC CODE; GERMINAL CENTER; GRAVES DISEASE; HASHIMOTO DISEASE; HEREDITY; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MONOZYGOTIC TWINS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYROID CELL; TRANSCRIPTOMICS; ANTIBODY DETECTION; CASE STUDY; DNA DETERMINATION; ENDOCRINE OPHTHALMOPATHY; FAMILY HISTORY; GENE EXPRESSION; GOITER; HYPERTHYROIDISM; HYPOTHYROIDISM; LYMPHOCYTE MIGRATION; MICROARRAY ANALYSIS; PATIENT COMPLIANCE; RISK FACTOR; TH1 CELL; TH2 CELL; THYROID SCINTISCANNING; TWIN DISCORDANCE;

ADOLESCENT; ANGIOGENIC PROTEINS; APOPTOSIS REGULATORY PROTEINS; CHEMOKINES; DISEASES IN TWINS; FEMALE; GRAVES OPHTHALMOPATHY; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; THYROID GLAND; TRANSCRIPTION, GENETIC; TWINS, MONOZYGOTIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 32844461980     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02063     Document Type: Article

References (37)

1. Armengol MP, Juan M, Lucas-Martin A, Fernandez-Figueras MT, Jaraquemada D, Gallart T & Pujol-Borrell R. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. American Journal of Pathology 2001 159 861-873.
2. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA & Davies TF. Common and unique susceptibility loci in Graves' and Hashimoto diseases: results of whole genome screening in a data set of 102 multiplex families. American Journal of Human Genetics 2003 73 736-747.
3. Jayson MI, Doniach D, Benhamou-Glynn N, Roitt IM & el Kabir DJ. Thyrotoxicosis and Hashimoto goitre in a pair of monozygotic twins with serum long-acting thyroid stimulator. Lancet 1967 2 15-18.
4. Chertow BS, Fidler WJ & Fariss BL. Graves' disease and Hashimoto's thyroiditis in monozygous twins. Acta Endocrinologica 1973 72 18-24.
5. Ilicki A, Marcus C & Karlsson FA. Hyperthyroidism and hypothyroidism in monozygotic twins: detection of stimulating and blocking THS receptor antibodies using the FRTL5-cell line. Journal of Endocrinological Investigation 1990 13 327-331.
6. Tani J, Yoshida K, Fukazawa H, Kiso Y, Sayama N, Mori K, Aizawa Y, Hori H, Nakasato N & Abe K. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports. Endocrine Journal 1998 45 117-121.
7. Brix TH, Kyvik KO & Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. Journal of Clinical Endocrinology and Metabolism 2000 85 536-539.
8. Brix TH, Kyvik KO, Christensen K & Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. Journal of Clinical Endocrinology and Metabolism 2001 86 930-934.
9. Ringold DA, Nicoloff JT, Kesler M, Davis H, Hamilton A & Mack T. Further evidence for a strong genetic influence on the development of autoimmune thyroid disease: the California twin study. Thyroid 2002 12 647-653.
10. Strieder TG, Prummel MF, Tijssen JG, Endert E & Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clinical Endocrinology 2003 59 396-401.
11. Prummel MF, Strieder T & Wiersinga WM. The environment and autoimmune thyroid diseases. European Journal of Endocrinology 2004 150 605-618.
12. Schott M, Scherbaum WA & Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves' disease. Trends in Endocrinology and Metabolism 2005 16 243-248.
13. Evans C, Morgenthaler NG, Lee S, Llewellyn DH, Clifton-Bligh R, John R, Lazarus JH, Chatterjee VK & Ludgate M. Development of a luminescent bioassay for thyroid stimulating antibodies. Journal of Clinical Endocrinology and Metabolism 1999 84 374-377.
14. Jordan NJ, Rinderle C, Ashfield J, Morgenthaler NG, Lazarus J, Ludgate M & Evans C. A luminescent bioassay for thyroid blocking antibodies. Clinical Endocrinology 2001 54 355-364.
15. Aust G, Sittig D, Becherer L, Anderegg U, Schütz A, Lamesch P & Schmücking E. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by Grave's disease. European Journal of Endocrinology 2004 150 225-234.
16. Hofmann A, Laue S, Rost A, Scherbaum WA & Aust G. mRNA levels of MT1-MMP, MMP-2, and MMP-9 and their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Thyroid 1998 8 203-214.
17. Aust G, Crisp M, Bösenberg E, Ludgate M, Weetman AP & Paschke R. Transcription of thyroid autoantigens in non-expressing tissues. Experimental and Clinical Endocrinology and Diabetes 1998 106 319-323.
18. Aust G, Steinert M, Kiessling S, Kamprad M & Simchen C. Reduced expression of stromal derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells. Journal of Clinical Endocrinology and Metabolism 2001 86 3368-3376.
19. Margolick JB, Weetman AP & Burman KD. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon gamma. Clinical Immunology and Immunopathology 1988 47 208-218.
20. Aust G, Lehmann I, Laue S & Scherbaum WA. Activated and IFN-gamma producing thyroid-derived T cells are detected in Graves' disease, thyroid autonomy as well as in non-toxic multinodular goiter. European Journal of Endocrinology 1996 135 60-68.
21. Davies TF. T-cell receptor gene expression in autoimmune thyroid disease: some observations and possible mechanisms. Annals of the New York Academy of Sciences 1995 756 331-344.
22. Quaratino S, Badami E, Pang YY, Bartok I, Dyson J, Kioussis D, Londei M & Maiuri L. Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nature Medicine 2004 10 920-926.
23. Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, Richiusa P, Galluzzo A & Giordano C. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease. Annals of the New York Academy of Sciences 2002 966 496-501.
24. Armengol MP, Cardoso-Schmidt CB, Fernandez M, Ferrer X, Pujol-Borrell R & Juan M. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4(+) T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. Journal of Immunology 2003 170 6320-6328.
25. Rotondi M, Lazzeri E, Romagnani P & Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. Journal of Endocrinological Investigation 2003 26 177-180.
26. Dogan RN, Vasu C, Holterman MJ & Prabhakar BS. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. Journal of Immunology 2003 170 2195-2204.
27. Nagayama Y, Watanabe K, Niwa M, McLachlan SM & Rapoport B. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. Journal of Immunology 2004 173 2167-2173.
28. Paschke R, Schuppert F, Taton M & Velu T. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. Journal of Endocrinology 1994 141 309-315.
29. Heuer M, Aust G, Ode-Hakim S & Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis and non-autoimmune thyroid disorders determined by quantitative reverse transcriptase chain reaction (RT-PCR). Thyroid 1996 6 97-106.
30. Ajjan RA, Watson PF, McIntosh RS & Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clinical and Experimental Immunology 1996 105 523-528.
31. Ajjan RA, Watson PF & Weetman AP. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism 1997 82 666-669.
32. Sato K. Vascular endothelial growth factors and thyroid disorders. Endocrine Journal 2001 48 635-646.
33. Wang CY & Chang TC. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism. Journal of Formosan Medical Association 2001 100 753-757.
34. Nagura S, Katoh R, Miyagi E, Shibuya M & Kawaoi A. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves' disease possibly correlated with increased vascular density. Human Pathology 2001 32 10-17.
35. Foley TP Jr, Schubert WK, Marnell RT & McAdams AJ. Chronic lymphocytic thyroiditis and juvenile myxedema in uniovular twins. Journal of Pediatrics 1968 72 201-207.
36. Townes PL & Bradford WL. Congenital hypothyroidism and hyperthyroidism in monozygotic twin girls. Journal of Medical Genetics 1971 8 471-477.
37. Tomer Y, Barbesino G, Greenberg DA, Concepcion E & Davies TF. Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. Journal of Clinical Endocrinology and Metabolism 1999 84 4656-4664.